Dyne Therapeutics Inc (NASDAQ: DYN) on Tuesday, plunged -0.75% from the previous trading day, before settling in for the closing price of $29.45. Within the past 52 weeks, DYN’s price has moved between $10.12 and $47.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 11.90%. With a float of $77.00 million, this company’s outstanding shares have now reached $101.77 million.
The firm has a total of 141 workers. Let’s measure their productivity. In terms of profitability, gross margin is 64.28%, operating margin of -8301.64%, and the pretax margin is -7774.92%.
Dyne Therapeutics Inc (DYN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Dyne Therapeutics Inc is 24.34%, while institutional ownership is 86.86%. The most recent insider transaction that took place on Nov 25 ’24, was worth 593,414. Before that another transaction happened on Nov 22 ’24, when Company’s Affiliate proposed sale 62,301 for $30.00, making the entire transaction worth $1,869,030.
Dyne Therapeutics Inc (DYN) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -1.09 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.93) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.90% per share during the next fiscal year.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Dyne Therapeutics Inc (DYN) is currently performing well based on its current performance indicators. A quick ratio of 17.02 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.56, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -3.76 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Analysing the last 5-days average volume posted by the [Dyne Therapeutics Inc, DYN], we can find that recorded value of 1.05 million was lower than the volume posted last year of 1.48 million. As of the previous 9 days, the stock’s Stochastic %D was 31.00%. Additionally, its Average True Range was 1.95.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 23.78%, which indicates a significant decrease from 25.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.81% in the past 14 days, which was higher than the 81.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.95, while its 200-day Moving Average is $32.45. Now, the first resistance to watch is $29.94. This is followed by the second major resistance level at $30.65. The third major resistance level sits at $31.32. If the price goes on to break the first support level at $28.56, it is likely to go to the next support level at $27.89. Now, if the price goes above the second support level, the third support stands at $27.18.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
Market capitalization of the company is 2.97 billion based on 101,766K outstanding shares. Right now, sales total 0 K and income totals -235,940 K. The company made 0 K in profit during its latest quarter, and -97,130 K in sales during its previous quarter.
